News from amgen inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 18, 2015, 16:00 ET
Amgen Logo.

Amgen Appoints Jonathan P. Graham Senior Vice President, General Counsel And Secretary

Amgen (NASDAQ: AMGN) today announced the appointment of Jonathan P. Graham as senior vice president, general counsel and secretary, effective July...

May 15, 2015, 04:00 ET
Amgen Logo.

Amgen Presents First Phase 2 Data For AMG 334 In The Prevention Of Episodic Migraine

Amgen (NASDAQ:AMGN) today announced the first results from its global Phase 2, double-blind, placebo-controlled study evaluating the efficacy and...

May 14, 2015, 17:58 ET
Amgen Logo.

Amgen Announces Voting Results of Annual Meeting of Stockholders

 Amgen (NASDAQ: AMGN) today announced voting results from the Company's Annual Meeting of Stockholders, held in Westlake Village, Calif. ...

May 13, 2015, 17:00 ET
Amgen Logo.

Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio

 Amgen (NASDAQ: AMGN) today announced that data at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) will...

May 12, 2015, 16:06 ET
Amgen Logo.

Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide Search For Champions In The Fight Against Cancer

 Amgen (NASDAQ: AMGN) today announced the 10 Breakaway from Cancer® Champions selected from a nationwide search for survivors, patients,...

May 11, 2015, 16:05 ET
Amgen Logo

Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society

 Amgen (NASDAQ:AMGN) today announced it will be presenting data for its calcitonin gene-related peptide (CGRP) receptor inhibitor AMG 334 at...

May 04, 2015, 16:17 ET
Amgen Logo.

Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference

 Amgen (NASDAQ: AMGN) will present at the Deutsche Bank 40th Annual Healthcare Conference at 8 a.m. ET on Thursday, May 7, 2015, at the...

Apr 29, 2015, 09:15 ET
Amgen Logo.

Amgen Announces FDA Advisory Committee Meeting To Review Repatha™ (Evolocumab) As A Treatment For High Cholesterol

 Amgen (NASDAQ: AMGN) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug...

Apr 29, 2015, 08:00 ET
Amgen Logo.

Amgen To Discuss Details Of The Biologics License Application For Talimogene Laherparepvec For Patients With Metastatic Melanoma

 Amgen (NASDAQ:AMGN) today announced that the Company will discuss the data supporting the Biologics License Application (BLA) for talimogene...

Apr 21, 2015, 16:01 ET
Amgen Logo.

Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48

Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2015. Key results include: - Total revenues increased 11...

Apr 16, 2015, 16:05 ET
Amgen Logo.

Amgen Announces Webcast Of 2015 First Quarter Financial Results

 Amgen (NASDAQ: AMGN) today announced that it will report its first quarter financial results on Tuesday, April 21, 2015, after the close of...

Apr 15, 2015, 17:04 ET
General Amgen Logo

FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure

 Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Corlanor® (ivabradine), an...

Apr 06, 2015, 05:00 ET
Amgen Logo.

European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer

Amgen (NASDAQ: AMGN) today announced that the European Commission approved a new use of Vectibix® (panitumumab) as first-line treatment in...

Mar 30, 2015, 16:07 ET
Amgen Logo.

Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference

 Amgen (NASDAQ: AMGN) will present at the Goldman Sachs Key Debates in Biosimilars conference at 9:05 a.m. ET on Thursday, April 2, 2015, at...

Mar 30, 2015, 09:00 ET
Amgen Logo.

FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma

Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of...

Mar 26, 2015, 16:01 ET
Amgen Breakaway from Cancer Logo.

Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer

Amgen (NASDAQ:AMGN) today announced that breast cancer survivor Joan Lunden has been named 2015 Honorary Breakaway from Cancer® Champion...

Mar 23, 2015, 09:00 ET
Amgen Logo.

Amgen To Webcast Investor Call At the 73rd Annual Meeting of the American Academy of Dermatology

 Amgen (NASDAQ:AMGN) will host a webcast call for the investment community at the 73rd Annual Meeting of the American Academy of Dermatology...

Mar 20, 2015, 09:00 ET
Amgen Logo.

Amgen Submits Application For Investigational LDL Cholesterol-Lowering Medication Repatha™ (evolocumab) In Japan

Amgen (NASDAQ: AMGN) today announced that an application seeking marketing approval of RepathaTM (evolocumab) for the treatment of high cholesterol...

Mar 17, 2015, 16:01 ET
Amgen Logo.

Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Dermatology

Amgen (NASDAQ:AMGN) today announced that it will present data from multiple brodalumab and Enbrel® (etanercept) studies at the 73rd Annual...

Mar 15, 2015, 11:00 ET
Amgen Logo

Amgen Publishes Safety Analysis Of Investigational Cholesterol-Lowering Medication Repatha™ (evolocumab) In The New England Journal of Medicine

 Amgen (NASDAQ: AMGN) today announced one-year data from prespecified exploratory endpoints of adjudicated cardiovascular events in the Phase 2...